Condition: Coronary Artery Disease · Chronic Coronary Syndrome · Acute Coronary Syndrome · Sponsor: Samsung Medical Center
The AIM-FFR trial is a prospective, multi-center, open-label, randomized controlled, non-inferiority trial. The current trial will evaluate non-inferiority of MPFFR-guided PCI, compared with invasive FFR-guided PCI in patients with coronary artery disease.
This description comes directly from the study's public registry record.
Joo Myung Lee, MD, MPH, PhD · 0234102575 · drone80@hanmail.net
Seung Hun Lee, MD, PhD · 821064137449 · lsh8602@naver.com
Always discuss trial participation with your own doctor first.
| Korea University Anam Hospital | Seoul, Select State, South Korea | Recruiting |
| Inje University Haeundae Paik Hospital | Busan, South Korea | Recruiting |
| Changwon Fatima Hospital | Changwon, South Korea | Recruiting |
| Gyeongsang National University Changwon Hospital | Changwon, South Korea | Recruiting |
| Keimyung University Dongsan Hospital | Daegu, South Korea | Recruiting |
| Kyungpook National University Hospital | Daegu, South Korea | Recruiting |
| Chonnam National University Hospital, Chonnam National University Medical School | Gwangju, South Korea | Recruiting |
| Chung-Ang University Gwangmyeong Hospital | Gwangmyeong, South Korea | Recruiting |
| CHA Bundang Medical Center | Gyeonggi-do, South Korea | Recruiting |
| Wonkwang University Hospital | Iksan, South Korea | Recruiting |
| Inje University College of Medicine, Ilsan Paik Hospital | Ilsan, South Korea | Recruiting |
| Gachon University Gil Medical Center | Incheon, South Korea | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07329699